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Abstract Spinal muscular atrophy is a neurodegenerative
disorder caused by mutations or deletions in the survival motor
neuron (SMN) gene. We have cloned the Drosophila ortholog of
SMN (DmSMN) and disrupted its function by ectopically
expressing human SMN. This leads to pupal lethality caused
by a dominant-negative effect, whereby human SMN may bind
endogenous DmSMN resulting in non-functional DmSMN/
human SMN hetero-complexes. Ectopic expression of truncated
versions of DmSMN and yeast two-hybrid analysis show that the
C-terminus of SMN is necessary and sufficient to replicate this
effect. We have therefore generated a system which can be
utilized to carry out suppressor and high-throughput screens, and
provided in vivo evidence for the importance of SMN oligomer-
ization for SMN function at the level of an organism as a
whole. ß 2000 Federation of European Biochemical Societies.
Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Spinal muscular atrophy (SMA) is a common autosomal
recessive disorder characterized by loss of lower motor neu-
rons of the spinal cord [1]. The neuronal degeneration leads to
a variable degree of muscular wasting and atrophy, and its
most severe manifestation (Type I, Werdnig^Ho¡mann dis-
ease) is the most common genetic cause of infant mortality
[2]. SMA results from mutations or deletions in the survival
motor neuron (SMN) gene [3]. SMN exists in two copies in a
duplicated region of chromosome 5q13 [4]. The telomeric ver-
sion (SMN1) generates a full-length SMN protein, whereas
the centromeric counterpart (SMN2) gives rise mainly to al-
ternatively spliced forms [5]. SMN1 is deleted or mutated in
s 98% of SMA patients [3]. Consistently, the absence or a
reduced level of functional full-length SMN protein is the
primary cause of the neuromuscular degeneration observed
in SMA [3,6]. The copy number of SMN2 has been shown
to determine disease severity [7], but the relative contribution
of its alternatively spliced transcripts to alleviating the lack of
SMN1 is unclear. It is well established that SMN is part of a
multiprotein complex involved in the biogenesis of snRNPs
[8,9] and pre-mRNA splicing [10]. However, these ¢ndings do
not explain the absolute speci¢city of motor neuron death;
rather they suggest, together with the ubiquitous expression of
SMN, a housekeeping function for this gene.
The study of Drosophila homologs of many human genes
has provided new insight into fundamental aspects of protein
function. The creation of Drosophila models for human dis-
ease is a powerful tool to genetically de¢ne disease mechanism
and modi¢er genes [11]. The evolutionary conservation of the
SMN gene, together with the absence of such a genetic tool
for SMA, prompted us to clone and characterize the Droso-
phila melanogaster SMN (DmSMN) gene. In this paper we
disrupt SMN function in Drosophila, thereby generating a
system which can be utilized to carry out suppressor and
high-throughput screens. In addition, we provide in vivo evi-
dence for the importance of the SMN C-terminal domain for
SMN function at the level of a whole organism.
2. Materials and methods
2.1. Sequence characterization
A number of ESTs similar to human SMN were identi¢ed following
a search of the EST database at BDGP (http://www.fruit£y.org/
blast/). Two ESTs (LD36948, accession number AI456812 and
LD38096, accession number AI518549) were obtained and fully se-
quenced. These sequences, together with the partially sequenced
clones already available in the database, allowed the determination
of the full-length DmSMN mRNA. Comparison of this assembled
sequence with the Drosophila genomic database identi¢ed the
DmSMN genomic region (accession number AC020221) and showed
that the DmSMN gene contained no introns.
2.2. In situ hybridization
Antisense DmSMN RNA was synthesized from linearized template
cloned into the pGEM-T vector (Promega, UK) using the SP6/T7
Transcription kit (Roche, UK). The template used was a 680 bp frag-
ment corresponding to the entire DmSMN coding sequence. A com-
plementary sense DmSMN RNA probe generated in a similar fashion
was used as a negative control. In situ hybridization of whole mount
Drosophila embryos was performed as previously described [12].
2.3. Drosophila genetics
Fly stocks were maintained at 25‡C on standard medium. The
coding sequences of human SMN, DmSMN and fragments of
DmSMN were ampli¢ed using primers containing KpnI sites. The
resulting fragments were subcloned into the pUAST transformation
vector [13]. For each construct, at least three independent single-in-
sertion lines were established and used for further experiments. The
GAL4 line P{GawB}how[24B] was used to drive ectopic expression of
all the transgenes. P{GawB}how[24B] expression is observed in em-
bryonic mesoderm, becoming restricted to myogenic cells and being
detected in third-instar larval imaginal discs [14]. Crosses were per-
formed by mating females homozygous for P{GawB}how[24B] with
males homozygous for the UAS insertions.
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2.4. Yeast two-hybrid analysis
Yeast two-hybrid analysis was performed using the ProQuest Two-
Hybrid system (Life Technologies) as previously described [15].
3. Results and discussion
3.1. DmSMN sequence characterization and in situ analysis
A number of SMN-like sequences in several animal species
have previously been reported [16], indicating SMN orthologs
in vertebrates, the nematode Caenorhabditis elegans and yeast.
Several ESTs similar to the human SMN gene were identi¢ed
following a search of the Drosophila EST database (http://
www.fruit£y.org/blast/). The full-length £y SMN cDNA
(DmSMN) sequence was assembled from these overlapping
ESTs. DmSMN exhibits a signi¢cant overall homology to
other SMN orthologs (Fig. 1) and is the only SMN-like se-
quence in the Drosophila genome. In situ hybridization shows
that the DmSMN mRNA is expressed ubiquitously from
early, pre-transcriptional [17] stages of embryonic develop-
ment (Fig. 2). This suggests that the transcript is transmitted
maternally, in accord with previous observations in verte-
brates and nematodes [18,19].
3.2. Ectopic expression of human SMN results in pupal
lethality in Drosophila
To investigate SMN function in Drosophila, £ies transgenic
for several SMN constructs were generated using P-element-
mediated transformation. Transgene expression was subse-
quently achieved using the GAL4-UAS system [13], a well-
de¢ned inducible system in which the gene of interest is placed
under the control of a GAL4-inducible promoter. The GAL4
activator is provided by a second transgene containing GAL4
under the control of tissue-speci¢c promoter/enhancer ele-
ments. Over-expression of full-length DmSMN under these
conditions was generally benign; occasionally, a low percent-
age (6 5%) of embryonic lethality was observed, but no ef-
fects were apparent at later stages of the £y life cycle. In
contrast, ectopic expression of human SMN resulted in pupal
lethality (Fig. 3). Pupae developed until a relatively late stage,
but failed to eclose. A variety of morphogenetic and di¡er-
entiation defects could be observed instead. The penetrance
was absolute for most of the independent human SMN inser-
tions.
Fig. 1. Evolutionary conservation of SMN orthologs. The multiple alignment was constructed using Clustal W [28,29] and displayed using the
BOXHADE server (http://www.ch.embnet.org/software/BOX_form.html). Species: can, Canis familiaris ; hum, Homo sapiens ; mus, Mus muscu-
lus ; zeb, Danio rerio ; cel, C. elegans ; dros, D. melanogaster and pom, Schizosaccharomyces pombe. Homology is particularly signi¢cant at those
regions that are thought to be functionally signi¢cant, i.e. amino acids 19^60 (SIP1 [8] and RNA [20] binding domain), amino acids 91^143 (tu-
dor domain [23]) and amino acids 240^278 (binding to Sm proteins [8] and oligomerization [6] domain) in the human sequence. The DmSMN
cDNA sequence is available from GenBank/EMBL/DDBJ under accession number AF296281.
Fig. 2. In situ hybridization of DmSMN. A: A stage-4 embryo is
shown in a lateral view, anterior to the left. The DmSMN transcript
is already detectable at the cortical yolk-free cytoplasm underlying
the blastoderm nuclei located at the periphery. The presence of
DmSMN mRNA at this stage suggests that the transcript is trans-
mitted maternally [17]. B: A stage-12 embryo is viewed from a lat-
eral perspective, with dorsal up and anterior to the left. DmSMN
expression appears widespread. C: A complementary sense DmSMN
RNA probe was used as a negative control; no staining is detected
in a stage-13 embryo.
FEBS 24343 4-12-00 Cyaan Magenta Geel Zwart
I. Miguel-Aliaga et al./FEBS Letters 486 (2000) 99^102100
3.3. Ectopic expression of the C-terminus of DmSMN results in
identical phenotypes
The di¡erent behavior of the two orthologs suggested that
their functional similarity would be only partial ; while this
similarity would be su⁄ciently high for human SMN to some-
how interfere with endogenous DmSMN metabolism, the
functions of DmSMN and human SMN would not be com-
pletely interchangeable. An internal triplication of a YxxG
motif within the C-terminus of the protein is highly conserved
in all the SMN orthologs which have been reported so far
(Fig. 1). An essential role for this domain has been proposed
on the basis of this sequence similarity [16], a proposal sup-
ported by the fact that the mutations or deletions observed in
SMA patients usually include this region of the protein. In
vitro studies have shown that the C-terminus of SMN is nec-
essary and su⁄cient for oligomerization of the protein in ver-
tebrates [20], nematodes [19] and yeast [21]. Oligomerization
facilitates binding to Sm proteins and is essential for SMN
function [22]. We wondered whether our in vivo phenotypes
were a consequence of a dominant-negative e¡ect, whereby
human SMN would bind endogenous DmSMN through the
highly conserved C-terminal domain, but the resulting hetero-
complexes human/£y SMN would not be totally functional.
As a consequence, DmSMN would be titrated out, resulting
in overall loss of endogenous SMN function. To address this
question, several transgenic lines for truncated versions of
DmSMN were generated (Fig. 4). When ectopic expression
was induced, the C-terminal domain of DmSMN only (C-
DmSMN) and a NH2-terminal deletion fragment of DmSMN
(vN-DmSMN) resulted in identical phenotypes to those ob-
served with ectopic expression of human SMN. By contrast,
none of the other truncated forms, including DmSMN lacking
the C-terminus (vC-SMN, analogous to SMNv7, a natural
human splice isoform [5]), replicated this e¡ect. This suggests
that the C-terminus of SMN is necessary and su⁄cient to
generate a dominant-negative phenotype. Thus, deletion frag-
ments of DmSMN in which essential functional domains have
been removed are able to mimic the e¡ects of ectopic human
SMN expression.
3.4. DmSMN can self-associate and bind to human SMN
through its C-terminal region
To determine the molecular nature of the genetic interac-
tions observed, the ability of these dominant-negative forms
to oligomerize was assessed using the yeast two-hybrid system
(Fig. 5). The entire coding sequence of DmSMN was used as
bait against prey constructs containing DmSMN, C-DmSMN,
vN-DmSMN and human SMN. All these interactions were
positive, indicating that DmSMN self-associates through its
C-terminal domain. In addition, this interaction is evolutio-
narily conserved, and hetero-oligomerization of £y and hu-
man SMN proteins can occur.
Fig. 3. Ectopic expression of human SMN. A: Typical pupal-lethal
phenotype; wings and legs are abnormally positioned towards the
anterior end of the pupae. Two out of ¢ve transgenic lines died at
an earlier, white-pupal stage. B: Dissected dead pupae displaying
morphogenesis defects in head, legs and wings. A necrotic ring ter-
minates posterior development. C: A few pharate £ies escape lethal-
ity in the milder lines (two out of ¢ve); the tarsi of the second and
third pair of legs are abnormal (arrow). No pharate adults eclosed
in any of the other lines. D: Detail of abnormal leg (right) versus
wild-type (left). Tarsi are shorter and thicker.
Fig. 4. Deletion fragments of DmSMN. Transgenic £ies for single
DmSMN domains and DmSMN fragments lacking speci¢c domains
were generated. A: A schematic representation of the domains in-
cluded in each transgene. B: Amino acid composition of each dele-
tion fragment. The function of the equivalent human or mouse do-
mains, when this has been elucidated, is indicated. These functions
include binding to SIP1 [8], RNA/DNA [6], Sm proteins [8] and
Gemin3 [25]. The tudor domain facilitates binding to Sm proteins
[22] and the C-terminus is involved in oligomerization [20].
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3.5. Insights into SMN function and SMA etiology
We have cloned and characterized the DmSMN ortholog.
Our results show that SMN function can be disrupted specif-
ically in the fruit £y by taking advantage of the partial sim-
ilarity of function among SMN orthologs. This can be
achieved by ectopic expression of either human SMN or trun-
cated forms of DmSMN encompassing its C-terminal domain.
Previous experiments using more simple systems suggested a
link between SMA etiology and abnormal C-terminal function
[6,22]. Our results provide in vivo evidence for the role of this
C-terminal region in SMN function (involving oligomeriza-
tion and/or Sm protein binding) at the level of the organism
as a whole. In contrast, neither the central domain of
DmSMN (which corresponds to a tudor domain [23]) nor
fragments lacking the C-terminus (N-DmSMN or vC-
DmSMN) resulted in a dominant-negative phenotype.
SMNv7, the human equivalent of vC-DmSMN, is the main
product of SMN2, the centromeric copy of the human SMN
gene [5]. It is not clear whether this alternatively spliced tran-
script is functional, deleterious or irrelevant to SMN function.
In our system, no detrimental e¡ect could be observed. Over-
all, our strategy has proved to be a useful way to dissect
functional domains from an evolutionary point of view.
A growing number of SMN binding partners and, conse-
quently, putative SMN functions are being reported [24^27] It
is therefore essential to establish which of them are function-
ally signi¢cant, so that they can be targeted to compensate for
the absence of SMN. From a therapeutic perspective one can
attempt to up-regulate the small amount of full-length SMN
protein generated by SMN2 [7]. This strategy is supported by
the observation that over-expression of DmSMN did not re-
sult in a deleterious phenotype under our experimental con-
ditions. Alternatively, a more informative approach is to try
to discover new genes which could be targeted to compensate
for the absence of SMN. In order to achieve this goal, high-
throughput and suppressor screens need to be carried out.
These require a simple (yet in vivo) model which combines
speci¢city with ease of manipulation. We have generated a
suitable model, thereby opening the way to the development
of novel therapeutic strategies for SMA.
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Fig. 5. Yeast two-hybrid analysis of DmSMN binding properties.
DmSMN, human SMN, vN-DmSMN and C-DmSMN prey con-
structs were transformed, together with a DmSMN bait construct,
into the host yeast strain MaV203 [15]. Induction of the LacZ gene
was con¢rmed by assaying with X-Gal. The middle column shows
positive interaction between DmSMN and (from top to bottom) it-
self, vN-DmSMN, C-DmSMN and human SMN. On the right are
two patches each of ¢ve yeast control strains containing interacting
proteins of varying strengths (no interaction in strain a to strong in-
teraction in strain e). No self-activation was observed for the prey
constructs (left column) or the DmSMN bait construct (four patches
at the top of middle column).
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